P350 Impact of one year of treatment with elexacaftor/tezacaftor/ivacaftor on clinical outcomes in adult patients with cystic fibrosis - first experience from Croatia
Autor: | Čičković, I. Lalić, Palković, T. Odobašić, Josić, L., Jelavić, M., Bambir, I., Markelić, I., Tješić-Drinković, D., Dugac, A. Vukić |
---|---|
Zdroj: | In Journal of Cystic Fibrosis June 2023 22 Supplement 2:S171-S172 |
Databáze: | ScienceDirect |
Externí odkaz: |